Skip to the content

FDA Medical Device Recalls (openFDA)

Thoratec Corp.: Thoratec Heartmate 3 Sealed Outflow Graft with Bend Relief, Sterile, REF 105581US/105581, RX only, Part of Left Ventricular Assist Device (LVAD) UDI: 00813024013266

Recall number
Z-2349-2019
Recalling firm
Thoratec Corp.
Product
Thoratec Heartmate 3 Sealed Outflow Graft with Bend Relief, Sterile, REF 105581US/105581, RX only, Part of Left Ventricular Assist Device (LVAD) UDI: 00813024013266
Status
Terminated
Initiated
2019-03-30
Posted
not on file
Terminated
2020-08-24
Reason
Outflow Graft leaking at the pump connection during the implantation process. If the C-Ring is insufficiently seated, it renders the device nonfunctional because the Outflow Graft connection will leak during the implant procedure.
Root cause
Process design
Action
On March 30, 2019 all consignees were hand delivered the "Urgent Medical Device Recall" letter. The recall letter stated the following: 1. Abbott is recalling 208 HeartMate 3 Outflow Graft units globally (87 within the US). An Abbott Representative will be contacting you within the coming weeks to identify the specific units that are impacted in your inventory and replace them. 2. In the interim, continued implants with the current HeartMate 3 Outflow Grafts can still be conducted with standard implant procedures by following the HeartMate 3 Instructions for Use. However, in addition to following the existing instruction of checking for blood leaks and bleeding at the Outflow Graft When the flow through the blood pump is satisfactory, we now recommend that adequate performance of the Screw Ring attachment to the pump be evaluated before the device is brought to the surgical field. If the Screw Ring does not function properly, the Outflow Graft should be replaced with a backup Outflow Graft. Patient Management Recommendations 3. For patients implanted with the HeartMate 3 Left Ventricular Assist System (LVAS), Abbott confirms there is no risk due to this issue. Patients should be managed per standard clinical practice. 4. Please complete the acknowledgement form included in this packet and return to Abbott. If you are a consignee of this letter within your organization, please notify all users of the device within your organization. 5. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail, or by fax. " Complete and submit the report Online: www.fda.gov/medwatch/report.htm " Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed from, or submit by fax to 1-800-FDA-0178. 6. If you have questions,
Quantity
149 outflow graft units
Distribution
Worldwide distribution. US nationwide, Australia, Austria, Brazil, Canada, Cayman Islands, Chile, Colombia, Egypt, France, Germany, Greece, Singapore, Iran, Italy, Kuwait, Lebanon, Romania, Switzerland, Thailand, United Kingdom.
Lot, serial or model codes
105581/105581US: The shelf life is 60 months from date of manufacture. All batch/lot numbers 6613000 and below or 50000000 and higher.  UDI/GMDN 00813024013266 / 61747
510(k) numbers
not on file
PMA numbers
["P160054"]
Product code
DSQ
Firm FEI
2916596
Firm city
Pleasanton
Firm state
CA
Firm country
not on file

Where this comes from

Register
FDA Medical Device Recalls (openFDA)
Publisher
U.S. Food and Drug Administration (openFDA)
File
device-recall-0001-of-0001.json.zip
sha256
b87518bfe2e8
Published
2026-09-28
Read
2026-09-29T08:25:23.626Z

Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Search this register